Brought to you by:
-
Eastern Vascular Society, EVAR, John Homans Lecture, limb salvage, Presidential address, SVS president, VAM
New book penned by vascular icon charts career in surgery, revolutionary spirit
A new memoir penned by former Society for Vascular Surgery (SVS) President and vascular surgery leader Frank J. Veith, MD, which touches on a lifetime of service to the specialty and tackles some of its most monumental and controversial moments, was published this week. The Medical Jungle: A Pioneering Surgeon’s Battle to Revolutionize Vascular Care…
-
SVS: Pay 2023 dues to avoid lapse in benefits
Members, have any of you missed your most recent issue of Journal of Vascular Surgery (JVS)? If so, it could be because your 2023 Society for Vascular Surgery (SVS) dues have not yet been paid. As of Dec. 31, 2022, members with unpaid dues are considered no longer in good standing and thus unable to…
-
SVS Foundation: Get ‘Gatsby’ Gala tickets today
Tickets—both individual and for tables—are selling faster than a Gin Rickey during Prohibition for the Society for Vascular Surgery (SVS) Foundation’s “Great Gatsby Gala,” to be held at the 2023 Vascular Annual Meeting (VAM). From Feb. 3 to 18, individual tickets are $550. Starting Feb. 19, ticket prices will increase to $600 each. Tables of…
-
Back to basics: All the things I love about vascular surgery
Recently, after completing a difficult open aortic operation with my attending, a bright M3 asked me, “Why vascular surgery?” The question didn’t catch me off guard, as I always have a ready answer, and we had just finished a pretty awesome operation. Also, it was enlightening to hear how my attending stumbled upon vascular surgery.…
-
DCB, Eastern Vascular Society, Endologix, Midwestern Vascular Surgical Society, SVS president, VSITE, Women’s Vascular Summit
The top 10 most popular Vascular Specialist stories of December 2022
Among the most-read Vascular Specialist stories in December 2022 were the promising results from a postmarket surveillance study of a paclitaxel DCB; the Society for Vascular Surgery (SVS) paid tribute to the passing of former president James (Jimmy) S.T. Yao, MD; Monica Majumdar, MD, presenting data at the 2022 Eastern Vascular Society (EVS) annual meeting…
-
Deadline extension: VRIC 2023 abstracts now due Jan. 18
The Jan. 11 deadline to submit research abstracts on vascular disease and treatment for the 2023 Vascular Research Initiatives Conference (VRIC) has been extended to Jan. 18 due to a high volume of requests. With early-bird registration anticipated to open Feb. 1 for VRIC—which focuses on emerging vascular science and is considered the SVS’ annual…
-
SVS mourns passing of former president
Society for Vascular Surgery (SVS) members are mourning the death of James (Jimmy) S.T. Yao, MD, 88, former SVS president and Lifetime Achievement Award recipient. Yao, professor emeritus at Northwestern University, died Tuesday, Dec. 20, in Chicago. He had been a very active member of SVS since 1974, holding many roles, including that of president…
-
Students and residents: Attend VAM 2023 on a scholarship
Medical students and general surgery residents have the chance to change their lives. Perhaps they are still seeking some direction for their medical careers. Perhaps they’re considering vascular surgery but aren’t sure that’s right for them. A trip to the Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM) could be just what they need to…
-
‘Impressive’ 12-month Flex vessel prep data presented at VEITHsymposium
VentureMed Group, a medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for peripheral arterial disease (PAD), announced data presented at the 2022 VEITHsymposium (Nov. 15–19) in New York City that demonstrated that Flex vessel prep used prior to balloon angioplasty improves 12-month outcomes both in PAD and AV…
-
Paclitaxel DCB performs well in ‘challenging anatomy’ of femoropopliteal in-stent restenosis, VQI registry data show
The IN.PACT Admiral drug-coated balloon (DCB) shows promising results in treating femoropopliteal in-stent restenosis (ISR) in a Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) registry-based, postmarket surveillance study. This is according to Daniel Bertges, MD, a vascular surgeon from the University of Vermont Medical Center in Burlington, Vermont, who presented interim, 24-month data…